High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.

With the increasing ABSCT experience of the transplanting centres, the patients’ wish for a shorter stay in the hospital, increasing number of nosocomial infections and growing economic pressure, particularly in view of increasing absolute numbers of ABSCTs in Europe during the last decade [ 12 ], there is a clear trend towards outpatient treatment.

also in 19,460 other papers